Antibiotic market to reach US$ 74.07 billion by 2033; FDA approves GSK’s Blujepa for uncomplicated UTIs

Data Compilation
#PharmaFlow

Pipeline Prospector November 2025: Kimberly-Clark to buy Kenvue for US$ 48.7 bn; FDA approves Novartis’ gene therapy

Stock Recap
#PipelineProspector

Vortioxetine

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

65 API Suppliers, 28 USDMF, 3 JDMF, 14 EU WC, 10 KDMF, 10 NDC API, 42 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

67 Drugs in Development

67 Drugs in Development

INTERMEDIATES

19 Intermediate Suppliers

19 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

126 FDF Dossiers, 22 FDA Orange Book, 66 Europe, 6 Canada, 23 South Africa, 9 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 10MG BASE, TABLET;ORAL - EQ 15MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 20MG BASE, TABLET;ORAL - EQ 5MG BASE

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 14 SPI Pharma, 2 DKSH, 4 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 3 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 BASF, 1 Clariant, 3 DFE Pharma, 4 Gangwal Chemicals, 1 Ideal Cures, 2 Ingredion Pharma Solutions, 2 Kerry, 2 Keval Exports, 9 Microlex e.U, 2 Nitika Pharmaceutical Specialities, 2 Pharmatrans-Sanaq, 2 Pluviaendo, 3 Prachin Chemical, 14 Roquette, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 9 Sigachi Industries, 3 Silverline Chemicals, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

36 Fillers, Diluents & Binders, 17 Disintegrants & Superdisintegrants, 17 Direct Compression, 14 Chewable & Orodispersible Aids, 12 Taste Masking, 11 Thickeners and Stabilizers, 10 Lubricants & Glidants, 9 Co-Processed Excipients, 9 Granulation, 8 Coating Systems & Additives, 5 Parenteral, 4 Film Formers & Plasticizers, 3 Controlled & Modified Release, 2 Coloring Agents, 2 Rheology Modifiers, 2 Topical, 1 Emulsifying Agents, 1 Solubilizers, 1 Surfactant & Foaming Agents

DIGITAL CONTENT

2 Data Compilation #PharmaFlow, 46 News #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 17 Regulatory FDF Prices, 19 Annual Reports

MARKET PLACE

9 APIs, 4 FDF Dossiers, 1 Intermediates

PATENTS & EXCLUSIVITIES

80 US Patents, 8 US Exclusivities, 12 Health Canada Patents

REF. STANDARDS & IMPURITIES

8 Others

8 Others

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Registrant Name	Registration No.	Compound	Registration Date	Manufacturer	Manufacturer's Country	Manufacturer's Address
29/11/2025	Alembic Pharmaceuticals Limited	India	Seongwoo Chemical Co., Ltd.	Su473-29-ND	Vortioxetine hydrobromide	2022-09-16	Alembic Pharmaceuticals Limited (API Unit-lll)	India	API Division Karakhadi, Plot No. 842-843 Tal-Padra, AT.- Karakhadi-391 450, Dist.- Vadodara, Gujarat State, India.
29/11/2025	H. Lundbeck AS	Denmark	Lundbeck Korea Ltd.	Su4496-3-ND	Vortioxetine hydrobromide	2014-07-24	H. Lundbeck A/S@Jetpharma SA@Lundbeck Pharmaceuticals Italy SPA	Denmark	Oddenvej 182, Lumsas 4500 Nykøbing Sjælland, Denmark@Via Sottobisio 42 A, 6828 Balerna, Switzerland@Viale dell'Industria, 54 - 35129, Padova (PD), Italy

Vortioxetine

Vortioxetine

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

65 API Suppliers

28 USDMF

3 JDMF

14 EU WC

10 KDMF

10 NDC API

42 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

67 Drugs in Development

INTERMEDIATES

19 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

126 FDF Dossiers

22 FDA Orange Book

66 Europe

6 Canada

23 South Africa

9 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 10MG BASE

TABLET;ORAL - EQ 15MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 20MG BASE

TABLET;ORAL - EQ 5MG BASE

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc

14 SPI Pharma

2 DKSH

4 Gangwal Healthcare

1 Nanjing Well Pharmaceutical

1 Pfanstiehl

3 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

1 BASF

1 Clariant

3 DFE Pharma

4 Gangwal Chemicals

1 Ideal Cures

2 Ingredion Pharma Solutions

2 Kerry

2 Keval Exports

9 Microlex e.U

2 Nitika Pharmaceutical Specialities

2 Pharmatrans-Sanaq

2 Pluviaendo

3 Prachin Chemical

14 Roquette

3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shijiazhuang Huaxu Pharmaceutical

9 Sigachi Industries

3 Silverline Chemicals

3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

36 Fillers, Diluents & Binders

17 Disintegrants & Superdisintegrants

17 Direct Compression

14 Chewable & Orodispersible Aids

12 Taste Masking

11 Thickeners and Stabilizers

10 Lubricants & Glidants

9 Co-Processed Excipients

9 Granulation

8 Coating Systems & Additives

5 Parenteral

4 Film Formers & Plasticizers

3 Controlled & Modified Release

2 Coloring Agents

2 Rheology Modifiers

2 Topical

1 Emulsifying Agents

1 Solubilizers

1 Surfactant & Foaming Agents

DIGITAL CONTENT

2 Data Compilation #PharmaFlow

TABLET;ORAL - EQ 15MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons